MIT linQ
MIT linQ is an MIT-based academic innovation program that runs four cohort-based programs (Catalyst, IMPACT, IDEA², Rising Stars) using a proprietary needs-focused method to help postdoctoral researchers and students translate biomedical research into real-world health technologies, supported by grants and corporate Champions.
- Company typePrivate
- Founded2016
- HeadquartersCambridge, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What MIT linQ does
MIT linQ is an international innovation program based at the Massachusetts Institute of Technology in Cambridge, MA, founded in 2016 to accelerate and heighten the impact of biomedical research on health and society. The organization operates four cohort-based programs — Catalyst (project nucleation), IMPACT (career preparation for post-doctoral and advanced pre-doctoral trainees), IDEA² (commercialization mentorship for project teams), and Rising Stars (career development for women and underrepresented minorities) — all guided by the proprietary "linQ innovation method," a needs-focused framework that integrates medical, technological, and business perspectives to drive research from unmet-need definition toward real-world implementation.
Underlying the programs is a multidisciplinary community of faculty, fellows, and expert advisors from engineering, science, medicine, and business, drawn from MIT and partner institutions in the Boston area and internationally. Spinout technologies emerge from the cohorts, including PointCheck by Leuko Labs (a noninvasive white blood cell monitoring device for chemotherapy patients, originated in Catalyst). MIT linQ collaborates structurally with several MIT units — the Office of Innovation, the Deshpande Center for Technological Innovation, the Industrial Liaison Program, the Technology Licensing Office, and MIT Hacking Medicine — positioning itself as a connective layer across MIT's translational stack.
The business model is non-commercial: MIT linQ is funded through a combination of Champion organization sponsorships (e.g., GE Health, Cantabria Labs, PDS, Veterans Affairs, VHA Innovation Ecosystem, University of Debrecen), public agency grants (NIH, EIT Health), and MIT institutional support. Go-to-market is community-led, relying on MIT's brand, cohort recruitment, the linQ innovation method's reputation, and showcase placements such as the permanent "Essential MIT" exhibit at the MIT Museum (October 2022). Operations are run by a small core team (1–10 employees), led by Director Martha Gray, PhD, with program leadership distributed across Catalyst, IMPACT, IDEA², and Rising Stars leads.
MIT linQ firmographics
Firmographics- Name
- MIT linQ
- Legal name
- MIT linQ
- Website
- https://linq.mit.edu
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MIT linQ is an MIT-based academic innovation program that runs four cohort-based programs (Catalyst, IMPACT, IDEA², Rising Stars) using a proprietary needs-focused method to help postdoctoral researchers and students translate biomedical research into real-world health technologies, supported by grants and corporate Champions.
- Ownership category
- akta.pro rank
MIT linQ industry classification
Industry- Product category
- Biomedical Innovation Training Programs
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
- akta.pro primary industry
- AI & Machine Learning (Foundations & Applied) (EDAMACAG)
Keywords
Where MIT linQ is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MIT linQ business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Program sponsorship and grants: MIT linQ receives support through initiative sponsors, champion organizations that provide financial and intellectual support, and public agencies and foundations that fund program editions. This is a research/educational organization rather than a commercial entity.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
MIT linQ product offering
Product offeringCore offering
MIT linQ operates a structured biomedical technology innovation program portfolio built around the proprietary linQ innovation method. It runs four cohort-based programs—Catalyst, IMPACT, IDEA², and Rising Stars—that train researchers and clinicians to identify unmet medical needs, form multidisciplinary teams, develop commercialization strategies, and accelerate research-driven health technology projects from discovery to venture.
Product overview
MIT linQ is an innovation ecosystem comprising four interconnected programs designed to accelerate research-driven health technology development. The core programs include Catalyst (for nucleating high-potential biomedical technology projects), IMPACT (career preparation for post-doctoral and pre-doctoral trainees), IDEA² (mentorship and commercialization strategy for project teams), and Rising Stars (career development for women and underrepresented minorities). These programs are guided by the linQ innovation method and are designed to work together to help participants progress from identifying unmet medical needs through to launching new ventures. The portfolio also includes spinout technologies such as PointCheck by Leuko Labs, a noninvasive white blood cell monitoring device developed through the Catalyst program.
Differentiator
Problem solved
Functional benefit
Brands
- Catalyst: Program for nucleating high potential new projects without constraint of a single lab or institution. Cohorts of Catalyst Fellows identify and define unmet medical needs and develop new technologies.
- IMPACT
- IDEA²
- Rising Stars
Quantifiable outcome
- Innovation milestone achievement rates higher than MIT benchmark
Companies that use MIT linQ
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles2 records
MIT linQ technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
MIT linQ partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and major.
- Cantabria LabscoreChampions organization that provides financial and intellectual support to specific editions of linQ programs. Selected individuals from Champion organizations may meet with Fellows and project teams, offer comments and subject matter expertise on innovation priorities, and observe and learn about the program method.
- GE HealthcoreChampion organization providing financial and intellectual support to linQ programs. Offers subject matter expertise on innovation priorities and participates in program activities.
- PDScoreChampion organization providing financial and intellectual support to specific editions of linQ programs.
- Veterans Affairs (VA)coreChampion organization providing financial and intellectual support to linQ programs. VA Innovation Ecosystem also partners with linQ.
- VHA Innovation EcosystemcoreChampion organization providing financial and intellectual support to linQ programs for healthcare innovation.
- University of DebrecencoreChampion organization providing financial and intellectual support to linQ programs, representing international academic collaboration.
- EIT HealthmajorEuropean public agency and foundation that has funded program editions, promoting new paradigms for research and innovation in health technology across Europe.
- MIT Office of InnovationcoreInternal MIT unit that is part of linQ's network, collaborating on innovation initiatives across the MIT ecosystem.
- Deshpande Center for Technological InnovationcoreMIT center that is part of linQ's network, supporting technological innovation at MIT.
- MIT Industrial Liaison Program (ILP)coreMIT program that is part of linQ's network, facilitating industry connections and partnerships.
- MIT Technology Licensing Office (TLO)coreMIT office that manages technology commercialization and is part of linQ's innovation ecosystem.
- MIT Hacking MedicinecoreMIT initiative focused on healthcare hackathons and innovation that is part of linQ's broader innovation community.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
MIT linQ competitors and assessment
Company assessmentEmerging players
- Creative Destruction Lab: Seed-stage program for science-based startups with biomedical streams; comparable objective of turning academic research into fundable ventures, though structured as an objectives-based mentoring program.
- IndieBio: Biotech-focused accelerator that takes equity in biology startups; overlaps with linQ's venture-creation mission but operates as a for-profit accelerator rather than an academic program.
Regional players
- Imperial College Institute of Global Health Innovation: Imperial College London's health innovation institute that runs training and fellowship programs for biomedical innovators; similar mission to linQ but UK-based with different funder mix.
Direct peers
- EIT Health: European public-private partnership that funds biomedical innovation programs and is itself a Champion/funder of linQ; directly comparable as a multi-program biomedical innovation training and acceleration ecosystem.
- Stanford Byers Center for Biodesign: Stanford's flagship biomedical innovation fellowship program that trains multidisciplinary teams to identify unmet clinical needs and develop new health technologies — a near-direct analog to MIT linQ's Catalyst program in mission and structure.
- BioGenerator: St. Louis-based nonprofit that creates and funds early-stage life sciences companies, providing laboratory facilities, mentorship, and capital — comparable to linQ's role as a non-commercial biomedical venture-creation intermediary.
- MIT Hacking Medicine: MIT initiative that organizes healthcare hackathons and innovation events; explicitly listed as part of linQ's network and addresses the same healthcare innovation training mission through a different cohort format.
- UCSF Rosenman Institute: UCSF-affiliated health technology innovation platform that supports founders, clinicians, and investors in building medical device and digital health ventures; analogous to linQ's Catalyst/IDEA² functions in a different academic ecosystem.
Broad incumbents
- MIT Martin Trust Center for MIT Entrepreneurship: MIT's central entrepreneurship hub offering mentorship, programs, and funding to MIT-affiliated founders; comparable as an MIT-anchored entrepreneurship training organization but broader than biomedical-specific.
- MIT Deshpande Center for Technological Innovation: MIT center that funds and mentors faculty-led technology innovation projects across domains, including biomedical; overlaps with linQ's IDEA² mission but operates at faculty-project rather than postdoc/graduate cohort level.
Market position
Strengths4 records
Weaknesses3 records
Competitive moat5 records
Key risks4 records
Key highlights6 records
Customer concentration
MIT linQ social profiles
Digital presenceMIT linQ financial estimates
Financial estimateRevenue estimate
Valuation estimate
MIT linQ leadership team
Management profileNumber of profiles
Profiles5 records
MIT linQ funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MIT linQ M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MIT linQ
What does MIT linQ do?
MIT linQ operates a structured biomedical technology innovation program portfolio built around the proprietary linQ innovation method. It runs four cohort-based programs—Catalyst, IMPACT, IDEA², and Rising Stars—that train researchers and clinicians to identify unmet medical needs, form multidisciplinary teams, develop commercialization strategies, and accelerate research-driven health technology projects from discovery to venture.
Is MIT linQ a public or private company?
MIT linQ is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was MIT linQ founded?
MIT linQ was founded in 2016. It employs 1 to 10 people.
Where is MIT linQ based?
MIT linQ is headquartered in Cambridge, United States, in the North America region.
How does MIT linQ make money?
One revenue line is on record: program sponsorship and grants.
Who are MIT linQ's main competitors?
Emerging players on record are Creative Destruction Lab and IndieBio. Imperial College Institute of Global Health Innovation is listed as a regional player. Direct peers are EIT Health, Stanford Byers Center for Biodesign, BioGenerator, MIT Hacking Medicine and UCSF Rosenman Institute. Broad incumbents are MIT Martin Trust Center for MIT Entrepreneurship and MIT Deshpande Center for Technological Innovation.
Does MIT linQ have an API?
No public API is recorded for MIT linQ.
What industry is MIT linQ in?
MIT linQ's product category is Biomedical Innovation Training Programs. Its primary akta.pro industry code is EDAMACAG, AI & Machine Learning (Foundations & Applied). Its NAICS code is 5417 and its SIC code is 8731.